Oddo BHF Asset Management Sas Takes $7.24 Million Position in Amedisys, Inc. (NASDAQ:AMED)

Oddo BHF Asset Management Sas acquired a new stake in Amedisys, Inc. (NASDAQ:AMED) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund acquired 75,000 shares of the health services provider’s stock, valued at approximately $7,238,000. Oddo BHF Asset Management Sas owned approximately 0.23% of Amedisys as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Calamos Advisors LLC increased its stake in Amedisys by 11.6% during the 2nd quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider’s stock valued at $36,476,000 after purchasing an additional 41,220 shares in the last quarter. GAM Holding AG bought a new stake in Amedisys during the 2nd quarter valued at $275,000. Innealta Capital LLC bought a new stake in Amedisys during the 2nd quarter valued at $64,000. Signaturefd LLC increased its stake in Amedisys by 88.2% during the 2nd quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock valued at $104,000 after purchasing an additional 530 shares in the last quarter. Finally, Commonwealth Equity Services LLC increased its stake in Amedisys by 10.9% during the 2nd quarter. Commonwealth Equity Services LLC now owns 4,151 shares of the health services provider’s stock valued at $381,000 after purchasing an additional 409 shares in the last quarter. Institutional investors own 94.36% of the company’s stock.

Amedisys Stock Performance

Shares of AMED stock opened at $85.60 on Friday. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. The firm has a market capitalization of $2.80 billion, a PE ratio of 33.97, a price-to-earnings-growth ratio of 1.84 and a beta of 0.73. The firm has a fifty day simple moving average of $92.87 and a two-hundred day simple moving average of $95.02. Amedisys, Inc. has a 12 month low of $84.06 and a 12 month high of $98.95.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). The firm had revenue of $587.67 million for the quarter, compared to analysts’ expectations of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. Amedisys’s revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.98 earnings per share. Analysts forecast that Amedisys, Inc. will post 4.45 EPS for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.